BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32320030)

  • 1. The Role of Stereotactic Radiosurgery in the Management of Brain Metastases From a Health-Economic Perspective: A Systematic Review.
    Warsi NM; Karmur BS; Brar K; Moraes FY; Tsang DS; Laperriere N; Kondziolka D; Mansouri A
    Neurosurgery; 2020 Sep; 87(3):484-497. PubMed ID: 32320030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases.
    Lester-Coll NH; Dosoretz AP; Magnuson WJ; Laurans MS; Chiang VL; Yu JB
    J Neurosurg; 2016 Dec; 125(Suppl 1):18-25. PubMed ID: 27903191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic Radiosurgery in the Management of Limited (1-4) Brain Metasteses: Systematic Review and International Stereotactic Radiosurgery Society Practice Guideline.
    Chao ST; De Salles A; Hayashi M; Levivier M; Ma L; Martinez R; Paddick I; Régis J; Ryu S; Slotman BJ; Sahgal A
    Neurosurgery; 2018 Sep; 83(3):345-353. PubMed ID: 29126142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.
    Linskey ME; Andrews DW; Asher AL; Burri SH; Kondziolka D; Robinson PD; Ammirati M; Cobbs CS; Gaspar LE; Loeffler JS; McDermott M; Mehta MP; Mikkelsen T; Olson JJ; Paleologos NA; Patchell RA; Ryken TC; Kalkanis SN
    J Neurooncol; 2010 Jan; 96(1):45-68. PubMed ID: 19960227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
    Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
    J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the drivers of cost of management when patients with brain metastases are treated with upfront radiosurgery.
    Shenker RF; McTyre ER; Taksler GB; D'Agostino RB; Cramer CK; Ruiz J; Alphonse-Sullivan NK; Farris M; Watabe K; Xing F; Laxton AW; Tatter SB; Chan MD
    Clin Neurol Neurosurg; 2019 Jan; 176():10-14. PubMed ID: 30468997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local control and possibility of tailored salvage after hypofractionated stereotactic radiotherapy of the cavity after brain metastases resection.
    Bilger A; Bretzinger E; Fennell J; Nieder C; Lorenz H; Oehlke O; Grosu AL; Specht HM; Combs SE
    Cancer Med; 2018 Jun; 7(6):2350-2359. PubMed ID: 29745035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
    J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases.
    Patil CG; Pricola K; Sarmiento JM; Garg SK; Bryant A; Black KL
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD006121. PubMed ID: 28945270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of neurocognitive-sparing treatments for brain metastases.
    Savitz ST; Chen RC; Sher DJ
    Cancer; 2015 Dec; 121(23):4231-9. PubMed ID: 26372146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness Analysis of Stereotactic Radiosurgery Alone Versus Stereotactic Radiosurgery with Upfront Whole Brain Radiation Therapy for Brain Metastases.
    Kim H; Rajagopalan MS; Beriwal S; Smith KJ
    Clin Oncol (R Coll Radiol); 2017 Oct; 29(10):e157-e164. PubMed ID: 28552517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases.
    Chidel MA; Suh JH; Reddy CA; Chao ST; Lundbeck MF; Barnett GH
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):993-9. PubMed ID: 10863070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
    Singh C; Qian JM; Yu JB; Chiang VL
    J Neurosurg; 2019 Feb; 132(2):512-517. PubMed ID: 30771783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage whole brain radiotherapy or stereotactic radiosurgery after initial stereotactic radiosurgery for 1-4 brain metastases.
    Liu Y; Alexander BM; Chen YH; Horvath MC; Aizer AA; Claus EB; Dunn IF; Golby AJ; Johnson MD; Friesen S; Mannarino EG; Wagar M; Hacker FL; Arvold ND
    J Neurooncol; 2015 Sep; 124(3):429-37. PubMed ID: 26108659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy.
    Karlovits BJ; Quigley MR; Karlovits SM; Miller L; Johnson M; Gayou O; Fuhrer R
    Neurosurg Focus; 2009 Dec; 27(6):E7. PubMed ID: 19951060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors.
    Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Watanabe S; Kasuya H
    J Neurosurg; 2014 Dec; 121 Suppl():16-25. PubMed ID: 25434933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential impact of whole-brain radiotherapy added to radiosurgery for brain metastases.
    Kong DS; Lee JI; Im YS; Nam DH; Park K; Kim JH
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):385-9. PubMed ID: 20097485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.